文献速递慢阻肺

移动健康肺康复:一项随机对照等效性试验

Mobile health pulmonary rehabilitation (m-PR): a randomised controlled equivalence trial.
PubMed 文献 · Thorax · 2026-03-13

本研究为单盲多中心随机对照等效性试验,纳入90例慢阻肺患者,比较移动健康肺康复(m-PR)与中心肺康复(CB-PR)的疗效。结果显示,m-PR在6分钟步行距离上等效于CB-PR,在CAT评分上优于CB-PR,提示m-PR可作为具备数字素养的慢阻肺患者的管理选择。

要点

  • m-PR在改善6分钟步行距离上等效于中心肺康复。
  • m-PR在改善健康状态(CAT评分)上优于中心肺康复。
  • m-PR或可作为具备数字素养的慢阻肺患者的康复选择。

核心结论

  • 在慢阻肺患者中,mHealth肺康复在运动能力改善上等效于中心肺康复,在健康状态改善上优于中心肺康复。

研究设计与样本

  • 单盲、多中心、随机对照等效性试验,采用意向性分析。
  • 共随机90例慢阻肺患者,m-PR组44例,CB-PR组46例;完成至少一项主要结局评估者分别为38例和42例。
  • 干预为期8周,m-PR组使用移动肺康复应用程序并辅以电话支持,CB-PR组接受中心肺康复。

主要发现

  • 干预结束时,6分钟步行距离组间平均差异为13米(95%CI -6至31),表明m-PR等效于CB-PR。
  • 干预结束时,CAT评分组间平均差异为-4.9分(95%CI -7.2至-2.6),置信区间上下限均超出等效界值,表明m-PR优于CB-PR。

关键数值与推荐

  • 主要结局为6分钟步行距离和CAT评分的变化,等效界值分别为30米和2分。
  • m-PR组平均年龄75岁(SD 7),FEV1占预计值58%(SD 15);CB-PR组平均年龄75岁(SD 6),FEV1占预计值55%(SD 14)。

临床怎么用

  • 对于具备足够数字素养的慢阻肺患者,mHealth肺康复可作为中心肺康复的替代管理选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mobile health (mHealth) is a novel model of care that may overcome barriers to pulmonary rehabilitation (PR) access. This study determined if mHealth PR was equivalent to centre-based PR (CB-PR) in improving exercise capacity and health status in people with chronic obstructive pulmonary disease (COPD). METHOD: Single-blinded, multicentre, randomised controlled equivalence trial using an intention-to-treat analysis. Participants completed 8 weeks of either mHealth PR, using the mobile PR (m-PR) application and supported by telephone calls, or CB-PR. Co-primary outcomes, measured at baseline and end-intervention, were change in 6 minute walk distance (6MWD) and COPD assessment test (CAT) score, with an equivalence margin of 30 m and 2 points, respectively. RESULTS: 90 participants were randomised (mean (SD), m-PR n = 44: age 75 (7) years; forced expiratory volume in one second (FEV1) 58 (15) % predicted; CB-PR n = 46: age 75 (6) years; FEV1 55 (14) % predicted) with 38 m-PR participants and 42 CB-PR participants completing at least one primary outcome. At end-intervention, there was no between-group difference in 6MWD (mean difference (MD) 13 m, 95% CI -6 to 31), indicating equivalence of m-PR to CB-PR. There was a significant between-group difference in CAT score (MD -4.9 points, 95% CI -7.2 to -2.6), with both limits of the CI exceeding the equivalence margin, indicating superiority of m-PR. CONCLUSION: An mHealth PR programme resulted in equivalent improvements in exercise capacity and superior improvements in health status when compared with CB-PR in people with COPD. mHealth PR could be effective as a management option for people with COPD with adequate digital literacy. TRIAL REGISTRATION NUMBER: ACTRN12619001253190.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Brown SE, Wootton S, Dale MT, et al. Mobile health pulmonary rehabilitation (m-PR): a randomised controlled equivalence trial. Thorax. 2026. PMID: 40992935. doi:10.1136/thorax-2024-222823

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。